User profiles for Jose Iglesias

Jose IGLESIAS

- Verified email at cogeco.ca - Cited by 11227

Jose Iglesias

- Verified email at urjc.es - Cited by 4422

Jose Antonio Iglesias

- Verified email at inf.uc3m.es - Cited by 1484

[HTML][HTML] Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

…, E Van Cutsem, X Wei, J Iglesias… - … England Journal of …, 2013 - Mass Medical Soc
Background In a phase 1–2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine,
substantial clinical activity was noted in patients with advanced pancreatic cancer. We …

[HTML][HTML] Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

…, RL Korn, N Desai, V Trieu, JL Iglesias… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose The trial objectives were to identify the maximum-tolerated dose (MTD) of first-line
gemcitabine plus nab-paclitaxel in metastatic pancreatic adenocarcinoma and to provide …

Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS

J Iglesias, VE Abernethy, Z Wang… - American Journal …, 1999 - journals.physiology.org
We have previously shown that lysophosphatidic acid (LPA), an abundant serum lipid that
binds with high affinity to albumin, is a potent survival factor for mouse proximal tubular cells …

Cephalopod culture: current status of main biological models and research priorities

…, JP Andrade, IG Gleadall, J Iglesias… - Advances in marine …, 2014 - Elsevier
A recent revival in using cephalopods as experimental animals has rekindled interest in
their biology and life cycles, information with direct applications also in the rapidly growing …

[PDF][PDF] Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small …

…, JK Hon, V Hirsh, P Bhar, H Zhang, JL Iglesias… - J Clin Oncol, 2012 - academia.edu
Purpose This phase III trial compared the efficacy and safety of albumin-bound paclitaxel
(nab-paclitaxel) plus carboplatin with solvent-based paclitaxel (sb-paclitaxel) plus …

Heterogeneous acid catalysts for biodiesel production: current status and future challenges

JA Melero, J Iglesias, G Morales - Green Chemistry, 2009 - pubs.rsc.org
The reduction of oil resources and the consequent increasing price of oil distillates as well
as the environmental concerns of conventional fuels has renewed and increased interest on …

Biomass as renewable feedstock in standard refinery units. Feasibility, opportunities and challenges

JA Melero, J Iglesias, A Garcia - Energy & environmental science, 2012 - pubs.rsc.org
Within the present contribution we highlight the feasibility of standard refinery units for the
production of biofuels from different biomass-derived feedstock. The energy densification of …

[BOOK][B] Cephalopod culture

J Iglesias, L Fuentes, R Villanueva - 2014 - books.google.com
Cephalopod Culture is the first compilation of research on the culture of cephalopods. It
describes experiences of culturing different groups of cephalopods: nautiluses, sepioids (Sepia …

[HTML][HTML] Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19

P Kory, GU Meduri, J Varon, J Iglesias… - American journal of …, 2021 - journals.lww.com
Background: After COVID-19 emerged on US shores, providers began reviewing the emerging
basic science, translational, and clinical data to identify potentially effective treatment …

Rearing of Octopus vulgaris paralarvae: present status, bottlenecks and trends

J Iglesias, FJ Sánchez, JGF Bersano, JF Carrasco… - Aquaculture, 2007 - Elsevier
Due to the high mortality rates and poor growth generally observed in Octopus vulgaris
paralarval rearing experiments, it was decided to organize a working group in order to formulate …